Viewing Study NCT04926818

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-04-06 @ 10:57 AM
Study NCT ID: NCT04926818
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-30
First Post: 2021-06-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis (MS) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None relapsing multiple sclerosis View
None pediatric View
None relapse View
None EDSS View
None ofatumumab View
None siponimod View
None fingolimod View
None RMS View
None MS View